News & Events

Read QuantuMDx’s latest news to stay up to date with the company, its products, solutions and services.

News

QuantuMDx Takes Centre Stage at GIS23 Summit: Transforming Point-of-Care Molecular Diagnostics

We are delighted to share another achievement for QuantuMDx, and the North-East, within the molecular diagnostics space. On November 27th, 2023, QuantuMDx was invited to participate in the Global Investment Summit 2023 at Hampton Court Palace. This exclusive event brought…

Media Alert

QuantuMDx receives CTDA approval for sale of Q-POC™

NEWCASTLE UPON TYNE, UK 13 December, 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its…

Media Alert

QuantuMDx & Menarini Announce Exclusive Distribution Agreement

Agreement will initially cover the UK and France with potential to expand to other European…

Media Alert

QuantuMDx & Sansure Biotech Enters into Agreement

The agreement sets a roadmap for the commercialisation of Q-POC™ and its assays in China The two companies will collaborate to accelerate the development of new assays on the Q-POC™ platform Offers potential for component sourcing and manufacturing optimisation NEWCASTLE…

A supercharged platform, with a fast workflow

A smooth user experience behind each interaction, with an intuitive interface

A ready to use solution, with all its simplicity, accuracy and speed

A ton of tech behind every result, with intelligent multilingual software algorithms.

A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system

A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Care.

High quality multiplex PCR testing with the simplicity and speed of a lateral flow test

A sustainable respiratory infection control solution with the quality of lab-based PCR testing

Results you can trust, with a simple procedure and reliable testing

Meet the challenges of the Winter Season with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Care.

News & Events

QuantuMDx Takes Centre Stage at GIS23 Summit: Transforming Point-of-Care Molecular Diagnostics

QuantuMDx receives CTDA approval for sale of Q-POC™

QuantuMDx & Menarini Announce Exclusive Distribution Agreement

QuantuMDx & Sansure Biotech Enters into Agreement

Q-POC Platform

Respiratory Solution